27 Additionally, we found that urinary SPP1 was significantly elevated in FSGS patients, particularly in CKD stage III, with urinary SPP1 showing an increasing trend with disease progression and correlation with renal function indicators.
← all excerpts
Validation and Evaluation of SPP1 as a Candidate Biomarker for Disease Monitoring in Focal Segmental Glomerulosclerosis.
1
—
—